It is found that the formation and development of PAH are related to the increase of plasma 5-HT concentration, the up-regulation of the 5-HT transporter, and the enhancement of pulmonary vasoconstriction induced by 5-HT. The gene discussed is SLC6A4; the disease is pulmonary arterial hypertension.